CHARACTERIZATION OF 10 MARKER CHROMOSOMES IN A PROSTATIC-CANCER CELL-LINE BY INSITU HYBRIDIZATION

被引:19
|
作者
BROTHMAN, AR
PATEL, AM
机构
[1] EASTERN VIRGINIA MED SCH,DEPT PEDIAT,NORFOLK,VA 23501
[2] EASTERN VIRGINIA MED SCH,DEPT MICROBIOL IMMUNOL,NORFOLK,VA 23501
来源
CYTOGENETICS AND CELL GENETICS | 1992年 / 60卷 / 01期
关键词
D O I
10.1159/000133283
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Marker chromosomes contain potentially valuable information about breakpoints in cancer. However, routine banding procedures, by themselves, provide only limited information about the identity of marker chromosomes. In this study, the use of fluorescence in situ hybridization (FISH) with chromosome-specific centromeric probes and whole-chromosome-specific DNA libraries greatly enhanced the identification of 10 marker chromosomes in the primary prostatic cancer cell line PPC-1. Centromeric probes for chromosomes 1, 2, 3, 4, 10, 12, and 17 and whole-chromosome paint libraries for chromosomes 1, 2, 3, 4, 8, and 12, in conjunction with analysis of G-banded metaphases, allowed the major portion(s) of these 10 PPC-1 marker chromosomes to be defined. The results increase the number of identifiable chromosomal breakpoints in this cell line from 9 to 28 sites.
引用
收藏
页码:8 / &
相关论文
共 50 条
  • [31] ANALYSIS OF PROSTATIC FLUID - EVIDENCE FOR THE PRESENCE OF A PROSPECTIVE MARKER FOR PROSTATIC-CANCER
    GROVER, PK
    RESNICK, MI
    PROSTATE, 1995, 26 (01): : 12 - 18
  • [32] PROSTATE SPECIFIC ANTIGEN AS A SERUM MARKER FOR PROSTATIC-CANCER
    NEELS, H
    SMEUNINX, M
    FRANCK, F
    VANERPS, P
    DENIS, L
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1988, 26 (05): : 314 - 314
  • [33] PROSTATE ANTIGEN - A NEW POTENTIAL MARKER FOR PROSTATIC-CANCER
    WANG, MC
    PAPSIDORE, LD
    KURIYAMA, M
    VALENZUELA, LA
    MURPHY, GP
    CHU, TM
    PROSTATE, 1981, 2 (01): : 89 - 96
  • [34] CHARACTERIZATION OF MARKER CHROMOSOMES IN NAMALVA CELLS BY CHROMOSOMAL INSITU SUPPRESSION (CISS) HYBRIDIZATION AND R-BANDING
    RUPPERSBERGER, P
    ARNOLD, M
    ZANKL, H
    SCHERTHAN, H
    GENES CHROMOSOMES & CANCER, 1991, 3 (05): : 394 - 399
  • [35] PROSTATIC-CANCER CELL MOTILITY AND METASTASIS
    MOHLER, JL
    PARTIN, AW
    SHARIEF, Y
    BAKEWELL, WE
    COFFEY, DS
    SMITH, GJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 220 - 220
  • [36] IDENTIFICATION OF MARKER CHROMOSOMES IN A HUMAN MEDULLOBLASTOMA CELL-LINE (D283-MED)
    GRANT, G
    PATHAK, S
    MARIA, BL
    CANCER GENETICS AND CYTOGENETICS, 1988, 34 (02) : 247 - 250
  • [37] INSITU HYBRIDIZATION OF PCR AMPLIFIED INTER-ALU SEQUENCES FROM A HYBRID CELL-LINE
    DESMAZE, C
    ZUCMAN, J
    DELATTRE, O
    THOMAS, G
    AURIAS, A
    HUMAN GENETICS, 1992, 88 (05) : 541 - 544
  • [38] URINARY TISSUE FACTOR IN PROSTATIC-CANCER - A POTENTIAL DISEASE MARKER
    FRANCIS, JL
    ADAMSON, AS
    ROATH, OS
    WITHEROW, RO
    SNELL, ME
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1055 - 1055
  • [39] A PRELIMINARY-STUDY OF URINARY TRANSFERRIN AS A MARKER FOR PROSTATIC-CANCER
    FERNANDEZ, C
    RIFAI, N
    WENGER, AS
    MICKEY, DD
    SILVERMAN, LM
    CLINICA CHIMICA ACTA, 1986, 161 (03) : 335 - 339
  • [40] IMMUNOHISTOCHEMICAL LOCALIZATION OF ADCP - A POTENTIAL PROGNOSTIC MARKER IN PROSTATIC-CANCER
    TANKE, HJ
    WIJNEN, J
    TENKATE, J
    BOSMAN, FT
    KIRCH, J
    KAHN, PM
    JONAS, U
    JOURNAL OF UROLOGY, 1987, 137 (04): : A353 - A353